Airduo Respiclick Powder, Metered
Product Images NDC 59310-822

Product Visual Gallery

This gallery contains 24 technical images submitted to the FDA as part of the official labeling for Airduo Respiclick (NDC 59310-822). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Respiratory, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fp Chem Structure (Airduo Respiclick N208799 1)

Chemical structure of fluticasone propionate, one of the active ingredients in AirDuo RespiClick powder for inhalation by Teva Respiratory, LLC.*

FDA Label Image

Figure 8 (Airduo Respiclick N208799 10)

A line graph depicting the mean change in FEV1 (L) over a 12-hour period on Day 1 and Week 12 baseline for different groups of AirDuo RespiClick (Fluticasone Propionate and Salmeterol) at several dosages (232/14 mcg, 113/14 mcg), Fluticasone Propionate MDPI (232 mcg, 113 mcg), and placebo, illustrating respiratory efficacy measurements across time.*

FDA Label Image

Teva Logo (Airduo Respiclick N208799 11)

FDA Label Image

Teva Logo (Airduo Respiclick N208799 12)

FDA Label Image

Figure A (Airduo Respiclick N208799 13)

Illustration of the AirDuo RespiClick inhaler showing key components labeled: vent, mouthpiece, yellow cap, and dose counter. The diagram presents the inhaler from two angles, highlighting the yellow cap at the bottom and the dose counter on the back side of the device.*

FDA Label Image

Figure B (Airduo Respiclick N208799 14)

Illustration showing the dose counter on an AirDuo RespiClick inhaler. The 'Inhaler Full' view shows the counter at 60 doses remaining, and the 'Inhaler Empty' view shows the counter at 0 doses with a red indicator.*

FDA Label Image

Figure C (Airduo Respiclick N208799 15)

Illustration showing hands demonstrating the use of an AirDuo RespiClick inhaler. The image highlights the motion to open or activate the device, with the yellow inhaler cap being pushed down to produce a 'click' sound, indicating readiness for use.*

FDA Label Image

Figure D (Airduo Respiclick N208799 16)

Illustration showing correct and incorrect ways to attach a yellow cap to the AirDuo RespiClick inhaler device. The first image shows the correct method with a check mark, while the second and third images show incorrect methods with X marks, guiding proper assembly for use.*

FDA Label Image

Figure E (Airduo Respiclick N208799 17)

A black and white line drawing illustration showing a side profile of a human face with small dots dispersed from the mouth area, representing inhalation or aerosol spray release.*

FDA Label Image

Figure F (Airduo Respiclick N208799 18)

An instructional illustration showing a person using a metered-dose inhaler by placing the mouthpiece into their mouth and preparing to inhale. The inhaler device features a yellow-angled trigger or guard component near the mouthpiece, demonstrating correct positioning for respiratory administration of the medication.*

FDA Label Image

Figure G (Airduo Respiclick N208799 19)

Illustration showing a close-up view of the AirDuo RespiClick inhaler mouthpiece with the vent labeled. The diagram highlights the vent's location on the inhaler device used for respiratory powder delivery.*

FDA Label Image

Salmeterol Chem Structure (Airduo Respiclick N208799 2)

Chemical structure of the active ingredient in AirDuo RespiClick, Fluticasone Propionate and Salmeterol. The image shows a detailed molecular diagram representing the chemical composition of this dual-component respiratory inhalation powder medication.*

FDA Label Image

Figure H (Airduo Respiclick N208799 20)

Instructional illustration showing the use of the AirDuo RespiClick inhaler. A hand holds the inhaler while another hand is opening the yellow protective cap by lifting it upwards, indicated by a curved arrow.*

FDA Label Image

Teva Logo (Airduo Respiclick N208799 21)

FDA Label Image

Ndc 59310-805-06 Carton (55 mcg/ 14 mcg)

Packaging label for AirDuo RespiClick 55 mcg/14 mcg powder for inhalation, containing fluticasone propionate and salmeterol. The label shows metered powder dosage form with dose counter, manufactured by Teva Respiratory, LLC. The label includes dosage strength, active ingredients, NDC 59310-805-06, and instructions for use and storage.*

FDA Label Image

113 Mcg/ 14 Mcg Carton (NDC 59310-812-06)

AirDuo RespiClick 113 mcg/14 mcg powder, metered inhalation blister pack label. Contains Fluticasone propionate 113 mcg and Salmeterol 14 mcg. Label indicates prescription use, includes dosing information with dose counter, handling instructions, and safety information. Labeler is Teva Respiratory, LLC. The label features brand and generic names, strength, route of administration, and a barcode for scanning.*

FDA Label Image

232 Mcg/ 14 Mcg Carton (NDC 59310-822-06)

Packaging label for AirDuo RespiClick 232 mcg/14 mcg powder, metered inhalation. The label shows the proprietary name, generic names fluticasone propionate 232 mcg and salmeterol 14 mcg, route of administration (respiratory inhalation), and NDC 59310-822-06. The labeler is Teva Respiratory, LLC. The label includes directions to open the package and a barcode.*

FDA Label Image

Figure 1 (Airduo Respiclick N208799 3)

A chart presenting results from two clinical trials, Trial 201 and Trial 202, comparing the difference from placebo and 95% confidence intervals for fluticasone propionate formulations. The x-axis shows various treatment doses (mcg) with labels identifying fluticasone propionate multidose dry powder inhaler (Fp MDPI) and dry powder inhaler comparator (Fp DPI). The y-axis represents the difference from placebo values with confidence intervals for each treatment dose.*

FDA Label Image

Figure 2 (Airduo Respiclick N208799 4)

A line graph showing baseline-adjusted FEV1 (mL) over time (hours) for various Fluticasone Propionate and Salmeterol MDI and DPI formulations. The graph compares changes in FEV1 values across different dosages and delivery methods over a 12-hour period.*

FDA Label Image

Figure 3 (Airduo Respiclick N208799 5)

A line graph showing mean change in FEV1 (liters) over 12 weeks for five groups: AirDuo RespiClick 113 mcg/14 mcg, AirDuo RespiClick 55 mcg/14 mcg, Fluticasone Propionate MDI 113 mcg, Fluticasone Propionate MDI 55 mcg, and placebo. The graph tracks lung function improvement across these treatments with sample sizes listed for each group at weeks 0, 6, and 12.*

FDA Label Image

Figure 4 (Airduo Respiclick N208799 6)

A line graph showing the mean change in FEV1 (liters) over 12 hours from baseline on Day 1 for different treatments: AIRDUO RESPICLICK 113 mcg/14 mcg, AIRDUO RESPICLICK 55 mcg/14 mcg, Fluticasone Propionate MDPI 113 mcg, Fluticasone Propionate MDPI 55 mcg, and placebo. The y-axis represents mean change in FEV1, and the x-axis represents time in hours.*

FDA Label Image

Figure 5 (Airduo Respiclick N208799 7)

Line graph showing mean change in FEV1 (L) over 12 hours post-dose for AirDuo RespiClick (113 mcg/14 mcg and 55 mcg/14 mcg), Fluticasone Propionate MDI (113 mcg and 55 mcg), and placebo groups. The graph compares lung function change from baseline at day 1 and week 12 for these treatments.*

FDA Label Image

Figure 6 (Airduo Respiclick N208799 8)

A line graph showing mean change in FEV1 (L) over a 12-week period for AirDuo RespiClick 232 mcg/14 mcg and 113 mcg/14 mcg, Fluticasone Propionate MDPI 232 mcg and 113 mcg, and placebo groups. The x-axis represents weeks 0 to 12, and the y-axis shows mean FEV1 change from -0.1 to 0.5 L. Each treatment group is distinguished by different symbols and lines with a sample size listed at weeks 0, 8, and 12.*

FDA Label Image

Figure 7 (Airduo Respiclick N208799 9)

A line chart showing mean change in FEV1 (lung function) in liters over 12 hours post-dose from baseline on Day 1. It compares AirDuo RespiClick inhaler strengths 232 mcg/14 mcg and 113 mcg/14 mcg, Fluticasone Propionate MDPI at the same doses, and placebo. The graph shows values increasing soon after dosing, peaking early, then gradually declining over time.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.